Financial Comparison: Modular Medical (NASDAQ:MODD) and EssilorLuxottica (OTCMKTS:ESLOY)

EssilorLuxottica (OTCMKTS:ESLOY) and Modular Medical (NASDAQ:MODD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings for EssilorLuxottica and Modular Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EssilorLuxottica	0	1	5	2	3.13
Modular Medical	1	0	0	0	1.00

Earnings and Valuation

This table compares EssilorLuxottica and Modular Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EssilorLuxottica	$32.23 billion	3.20	$2.62 billion	N/A	N/A
Modular Medical	N/A	N/A	-$18.82 million	($0.49)	-0.32

EssilorLuxottica has higher revenue and earnings than Modular Medical.

Risk and Volatility

EssilorLuxottica has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500.

Profitability

This table compares EssilorLuxottica and Modular Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
EssilorLuxottica	N/A	N/A	N/A
Modular Medical	N/A	-245.85%	-190.80%

Insider & Institutional Ownership

0.0% of EssilorLuxottica shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

EssilorLuxottica beats Modular Medical on 8 of the 10 factors compared between the two stocks.

About EssilorLuxottica

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

About Modular Medical

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.